Stem cell research and the prospect of stem cell based therapies depend critically on the identification of specific markers that can be used for the identification and selection of stem and progenitor cells. Nestin is expressed in neuronal progenitor cells and has also been suggested to mark multipotent pancreatic stem cells. We show here that, throughout pancreatic development, markers of pancreatic progenitor cells and differentiated pancreatic cells are expressed in E-cadherin-positive epithelial cells that do not express nestin. The data presented demonstrate that nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas. q
Results and discussion
The prospect of treating diabetes by transplantation of insulin producing b-cells and the recent focus on human embryonic stem (ES) cells have fuelled an increased interest in the generation of b-cells from ES or pancreatic stem cells. The goal being to generate an infinitive supply of insulin producing cells that secrete insulin in a pulsatile manner at relevant blood glucose levels. The intermediary filament protein nestin has been suggested to be a marker for multipotent pancreatic stem cells of the pancreas (Hunziker and Stein, 2001; Zulewski et al., 2001 ) and nestin has been used to select ES-derived cells that generate insulin producing cells during in vitro differentiation (Lumelsky et al., 2001) . We have in detail analysed the expression of nestin during pancreatic development and show that nestin is expressed in the mesenchyme but not in the epithelium of the developing pancreas raising the issue of the cellular identity of insulin producing cells derived from nestin-positive ES cells.
Nestin was initially identified as a marker of neural stem or progenitor cells (Lendahl et al., 1990) and nestin expression has been used to select for ES cell-derived neuronal precursor cells which have been further induced to differentiate into neurons (Okabe et al., 1996; Lee et al., 2000) .
Nestin has also been suggested to be expressed in cells present in islets of adult pancreas (Hunziker and Stein, 2001; Zulewski et al., 2001) and in vitro studies claim that nestin-positive cells derived from isolated pancreatic islets can differentiate into pancreatic endocrine and exocrine cells (Zulewski et al., 2001 ). These results suggested that nestin might mark multipotent stem cells of the pancreas and by selecting for nestin-positive neuronal cells derived from mouse ES-cell, cells secreting insulin were generated (Lumelsky et al., 2001 ). These cells expressed, however, very low levels of insulin and most importantly lacked the expression of the transcription factor Ipf1/Pdx1, which is expressed in mature pancreatic b-cells and which is required for expression, processing and glucose regulated secretion of insulin (Ahlgren et al., 1998; Hart et al., 2000) .
Pancreatic endocrine cells share remarkable similarities with neuronal cells, including the expression of hormone/ neuropeptide processing enzymes, glucose transporters and transcription factors like NeuroD/BETA2, ngn3, Isl1, Pax-4, Pax-6, Nkx2.2, and Nkx6.1 (Le Douarin 1988; Edlund, 1998 Edlund, , 2001 ). In addition, neurons have the capacity to express insulin, as demonstrated by the expression of SV40 T-antigen under the control of the insulin promoter in the developing nervous system of transgenic mice (Alpert et al., 1988) . The similarities between pancreatic endocrine cells and neurons are further emphasized by the description of a patient with a brain tumour of neuroectodermal origin that presented with severe hypoglycemia and hyperinsulinemia (Nakamura et al., 2001) . The tumour cells of this patient expressed a number of transcription factors like ngn3, NeuroD/Beta22, and Isl1, i.e. factors that are also expressed in pancreatic endocrine cells, but lacked the expression of Ipf1/Pdx1, Pax4, and Nkx2.2 (Nakamura et al., 2001 ). Nevertheless, these brain tumour cells contained both proinsulin and insulin that, as implicated by the hyperinsulinemia that the patient presented with, also were secreted from these tumour cells (Nakamura et al., 2001 ). These findings demonstrate that neuroectodermal cells can both produce and secrete insulin in the absence of the key b-cell transcription factor Ipf1/ Pdx1.
To determine whether nestin is normally expressed in pancreatic stem or progenitor cells we examined the expression of nestin in the mouse pancreas at different stages of development using immunohistochemistry. Double-immunohistochemical analyses using antibodies specific for Ecadherin (E-cad) and nestin revealed that E-cadherin was expressed in epithelial structures of the gastrointestinal tract, including the pancreas, whereas nestin was expressed in the mesenchyme surrounding E-cad-positive epithelial structures (Fig. 1A-F) . From embryonic day 13 (e13) and onwards, nestin-positive mesodermal cells were scattered between the E-cad-positive lobulating pancreatic epithelium consistent with the growth and branching of the pancreatic epithelium into the surrounding mesenchyme and at no stage was nestin co-expressed with E-cad (Fig. 1G-I) . IPF1/PDX1 which is highly expressed in early pancreatic stem cells at e9-e10 and later selectively in differentiating b-cells (Ahlgren et al., 1998; Edlund, 1998 Edlund, , 2001 , and neurogenin 3 (ngn3) which is expressed in pancreatic progenitor cells (Edlund, 2001) , were throughout development co-expressed with E-cad ( Fig. 2A-J) . Isl1 which is expressed in all differentiated endocrine cells and in the mesenchyme surrounding the dorsal pancreatic mesenchyme (Edlund, 1998 (Edlund, , 2001 ) was as expected, expressed in both E-cad-positive and E-cad-negative cells (Fig. 1K-O) . The transcription factor p48 is expressed in differentiated exocrine cells and is required for the generation of the Fig. 1 . Nestin is expressed in mesenchymal cells and not pancreatic epithelial cells. (A-F) Analyses using anti-E-cad (green) and anti-nestin (red) antibodies revealed that the developing pancreatic and gastrointestinal epithelium express E-cad but not nestin. Nestin expression was restricted to the mesenchymal cells surrounding the epithelial structures of the gastrointestinal tract and the early pancreatic anlagen. As the E-cad-positive epithelium branches the nestin-positive mesenchymal cells become trapped between the pancreatic epithelium as is shown for e13 (D-I). (G-I) At later developmental stages and in the adult pancreas the nestin-positive cells were thus found dispersed throughout the E-cad-positive pancreatic epithelial cells. Abbreviations: dp, dorsal pancreas; vp, ventral pancreas; ste, stomach epithelium. Bar in A-F, 200 mm; in G-I, 100 mm.
exocrine pancreas (Krapp et al., 1988) . p48 is also expressed in early pancreatic progenitor cells (Li and Edlund, 2001 ) and these early p48-positive cells as well as p48-positive exocrine cells co-expressed E-cad (Fig. 2P-T) . Together, these data provide conclusive evidence that nestin is expressed in mesenchymal cells that surround the pancreatic epithelium and other developing gastrointestinal derivatives but not in pancreatic epithelial cells. Thus, our data demonstrate that nestin is not expressed in pancreatic epithelial cells at any stage of development.
The similarities between pancreatic endocrine cells and neurons and our finding that nestin is neither expressed in pancreatic progenitor cells nor in differentiated pancreatic cells, calls for caution in trying to generate b-cells from nestin-positive cells and emphasizes the need to understand in detail the normal development of the pancreas before time and effort are invested in generating insulin producing pancreatic b-cells suitable for transplantation of diabetic patients.
Materials and methods

Immunohistochemistry
Immunohistochemical localization of antigens was performed as described (Ahlgren et al., 1996; Ohlsson et al., 1993) . The primary antibodies used were rabbit anti-IPF1 (Ohlsson et al., 1993) , rabbit anti-ngn3 (generated against a GST-ngn3 fusion protein by AgriSeraAB), rabbit anti-ISL1 (Thor et al., 1991) , rabbit anti-p48 (Li and Edlund, 2001) , rabbit anti-nestin (kindly provided by U. Lendahl), and rat anti-E-cad (Zymed). The secondary antibodies used were fluorescein anti-rat (Jackson) and Cy3 anti-rabbit (Jackson).
Microscopy
Longitudinal sections of studied tissue were immunostained as described above. Images were collected on an epifluorescense microscope (Zeiss axioplan2) or Leica TCS SP confocal microscope fitted with spectrophotometer for emission band wavelength selection and dual detectors and argon/krypton (Ar/Kr) and Gre/Ne lasers for simultaneous scanning of two different fluorochromes. Confocal image stacks were combined as x-y projection images, digitally optimized, and assigned red and green pseudo-colours for Cy3 and fluorescein, respectively. . ngn3-positive endocrine progenitor cells (F-J) co-expressed E-cad throughout pancreatic development. Isl1 was co-expressed with E-cad in differentiated pancreatic endocrine cells (K,L). Note that Isl1 also is expressed in the E-cad negative mesechymal cells that surround the embryonic pancreatic epithelium (K). p48 was expressed in early E-cadpositive pancreatic progenitor cells (P) and in later appearing E-cad-positive exocrine cells (Q-T). Bar: 40 mm. members in our laboratory for helpful discussions. This work was supported by grants from the Swedish Research Council, the European Commission, and the Juvenile Diabetes Research Foundation, New York (to H.E).
